Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALF
Recent news which mentions ESALF
< Previous
1
2
Next >
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
July 26, 2024
Tickers
BIIB
ESALF
ESALY
LLY
Tags
why it's moving
News
Briefs
From
Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Tickers
BIIB
BMY
ESALF
JNJ
Tags
BMY
healthcare
BIIB
From
Benzinga
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
July 03, 2024
Tickers
BIIB
ESAIY
ESALF
LLY
Tags
Stories That Matter
Analyst Color
Movers
From
Benzinga
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
June 11, 2024
Tickers
BIIB
ESALF
LLY
NEWS
Tags
Equities
BIIB
AI Generated
From
Benzinga
European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab
March 22, 2024
Tickers
BIIB
ESALF
ESALY
NEWS
Tags
Stories That Matter
ESALF
General
From
Benzinga
Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer
December 08, 2023
Tickers
ESALF
ESALY
MRK
Tags
ESALF
General
Briefs
From
Benzinga
Biogen quarterly results top estimates despite complex launch of new Alzheimer’s treatment
November 08, 2023
Tickers
BIIB
ESALF
SPX
Tags
SPX
ESALF
BIIB
From
MarketWatch
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
November 06, 2023
Tickers
BIIB
ESALF
JNJ
LLY
Tags
BIIB
ESALF
JNJ
From
MarketWatch
Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge
November 02, 2023
Tickers
BIIB
ESALF
LLY
SPX
Tags
LLY
BIIB
ESALF
From
MarketWatch
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake
October 25, 2023
Tickers
BIIB
ESALF
LLY
Tags
LLY
BIIB
ESALF
From
MarketWatch
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage
October 13, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
BIIB
Health Care
AI Generated
From
Benzinga
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly
October 10, 2023
Tickers
BIIB
ESALF
ESALY
LLY
Tags
ESALY
News
Briefs
From
Benzinga
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
September 25, 2023
Tickers
AA
AAPL
AMZN
BIIB
Tags
WMT
F
RNAZ
From
Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
September 25, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
ESALF
Benzinga
From
Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
September 22, 2023
Tickers
ESALF
ESALY
MRK
Tags
ESALF
General
Briefs
From
Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
August 25, 2023
Tickers
ESALF
ESALY
MRK
Tags
Benzinga
MRK
Market News
From
Benzinga
Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
July 31, 2023
Tickers
BIIB
DGX
ESALF
LLY
Tags
DGX
SPX
ESALF
From
MarketWatch
Biogen to slash 1,000 jobs as it looks to save $700 million
July 25, 2023
Tickers
BIIB
ESALF
LLY
SAGE
Tags
SPX
ESALF
BIIB
From
MarketWatch
At-home Alzheimer’s testing is on the horizon, researchers say
July 19, 2023
Tickers
BIIB
ESALF
LLY
Tags
BIIB
LLY
ESALF
From
MarketWatch
Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain
July 17, 2023
Tickers
BIIB
ESALF
LLY
SPX
Tags
ESALF
SPX
LLY
From
MarketWatch
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
July 07, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Analyst Ratings
Market News
Trading Ideas
From
Benzinga
Biogen’s big Alzheimer’s drug win fails to boost the stock as analysts see slow Leqembi rollout
July 07, 2023
Tickers
BIIB
ESALF
LLY
Tags
LLY
BIIB
ESALF
From
MarketWatch
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
July 06, 2023
Tickers
BIIB
ESALF
LLY
Tags
BIIB
LLY
ESALF
From
MarketWatch
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
June 13, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALY
Briefs
News
From
Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
June 12, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Market News
Analyst Ratings
Trading Ideas
From
Benzinga
Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target
June 12, 2023
Tickers
AAPL
AMC
AMD
AMZN
Tags
ESALF
ORCL
BX:TMUBMUSD02Y
From
MarketWatch
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
June 12, 2023
Tickers
BIIB
CCF
CVNA
ESALF
Tags
CVNA
ESALF
ILMN
From
MarketWatch
FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment
June 09, 2023
Tickers
BIIB
ESALF
Tags
BIIB
ESALF
From
MarketWatch
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
Biotech
Health Care
BIIB
From
Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
June 08, 2023
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
General
News
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.